News | Hypertension | September 06, 2017

Text Messaging Could Help Tackle High Blood Pressure in At-Risk Patients

Michigan Medicine study will use emergency department-recorded blood pressure readings to follow up with patients electronically to try to improve health outcomes

Text Messaging Could Help Tackle High Blood Pressure in At-Risk Patients

Image courtesy of Michigan Medicine

September 6, 2017 — A new National Institutes of Health-funded hypertension trial will examine the possibility of using an emergency department setting to better identify people from central cities with limited access to other venues for medical care.

Of the 136 million annual visits to emergency departments, “nearly all of those visits have at least one time during the visit where the patient’s blood pressure is measured and recorded,” said William Meurer, M.D., an associate professor of emergency medicine at Michigan Medicine.

Which is why that setting could provide a prime chance to identify — and possibly treat — this patient population in need.

“Hypertension is the main risk factor for strokes,” said Lesli Skolarus, M.D., a Michigan Medicine associate professor of neurology and Meurer’s colleague at the University of Michigan Frankel Cardiovascular Center. “By identifying patients in the emergency department who may not know they have hypertension, we may be able to reach people who are not traditionally enrolled in hypertension programs.

“Specifically, we hope our strategy reduces cardiovascular disparities by enrolling subjects who are more likely to use the emergency department — African-Americans and socioeconomically disadvantaged patients — and have uncontrolled hypertension.”

Both physicians are co-principal investigators on the new $2.8 million trial intended to reach these patients and use text-messaging technology to help improve their outcomes after they are discharged.

“Socioeconomically disadvantaged patients are overrepresented in the emergency department, and these patients are at high risk for the consequences of untreated hypertension,” said Meurer, who, like Skolarus, is a member of the Institute for Healthcare Policy and Innovation and U-M’s Stroke Program. “So why wouldn’t this location be an appropriate place to help identify the health issue of high blood pressure and help them seek follow-up care?”

The trial, scheduled to begin in early 2018, will take place at Hurley Medical Center and Hamilton Community Health Center in Flint, Mich.

The U-M Department of Emergency Medicine has a longstanding relationship with Hurley’s emergency department. They have partnered on research and patient care many times in recent years.

Meurer, Skolarus and their team developed a health behavioral intervention called Reach Out, which they plan to use throughout the trial.

The project includes three mobile-messaging components:

  • Text messages to promote healthful behavior habits;
  • Tailored reminders to prompt self-monitoring of blood pressure; and
  • Primary care provider appointment scheduling and transportation.

Starting the process is intuitive, according to the researchers. “Once the patient’s blood pressure is recorded into their electronic health record within the emergency department, the record system will be able to identify those patients that have hypertension and enroll them in the Reach Out intervention,” Meurer said. “They’ll begin to receive text messages, and if they continue to record high blood pressure and responsiveness to the texts, they will be randomized and studied for 12 months.

“Our main goal is to see if an emergency department-initiated health intervention meaningfully reduces blood pressure.”

The research team plans to analyze each component individually, as well as in combination, to try to identify which factors contribute to improved patient health in at-risk urban communities.

They anticipate enrollees who receive primary care provider appointment scheduling and transportation will have greater primary care follow-up compared with those who do not receive the added services.

That step could help the interventions be most effective in the long run.

“Patients in underserved communities don’t always have a primary care provider, and that’s generally why we see them in the emergency department for their regular care,” Meurer said. “We hope Reach Out can connect underserved patients to primary care providers in an effort to improve chronic disease management in these populations.”

Read the related articles:

How Smartphones and Apps May Change the Face of Healthcare

The Uberization of Healthcare

Reducing Heart Failure Readmissions With Patient-Generated Health Data Analysis

 

For more information: www.med.umich.edu

Related Content

DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Marijuana Associated With Three-Fold Risk of Death From Hypertension
News | Hypertension| September 14, 2017
Marijuana use is associated with a three-fold risk of death from hypertension, according to research published recently...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Medtronic Announces Japanese Regulatory Approval for In.Pact Admiral Drug-Coated Balloon
News | Drug-Eluting Balloons| September 13, 2017
Medtronic plc announced that the In.Pact Admiral Drug-Coated Balloon (DCB) received approval from the Japanese Ministry...
PQ Bypass Reports Positive Results for Detour System in Patients With Long Femoropopliteal Blockages
News | Peripheral Artery Disease (PAD)| September 13, 2017
A subset analysis of the DETOUR I clinical trial showed promising safety and effectiveness results of PQ Bypass’ Detour...
News | Cardiac Diagnostics| September 12, 2017
Contracting shingles, a reactivation of the chickenpox virus, increases a person’s risk of stroke and heart attack,...
Vascular screening for abdominal aortic aneurysm, peripheral artery disease and hypertension during the VIVA Study in Denmark

Vascular screening for abdominal aortic aneurysm, peripheral artery disease and hypertension during the VIVA Study. Photo credit: Lisbeth Hasager Justesen, Viborg Hospital.

News | Cardiac Diagnostics| September 12, 2017
September 12, 2017 — A new screening program for vascular disease saves one life for every 169 men assessed, accordin
Overlay Init